Urapidil Hydrochloride is a phenylpiperazine derivative and an antihypertensive agent used to manage hypertensive emergencies, including pre-eclampsia, eclampsia, and severe blood pressure elevation during… Read more










Urapidil Hydrochloride is a phenylpiperazine derivative and an antihypertensive agent used to manage hypertensive emergencies, including pre-eclampsia, eclampsia, and severe blood pressure elevation during surgical procedures. By acting as a postsynaptic alpha-1 adrenoceptor antagonist and a 5-HT1A receptor agonist, this drug lowers blood pressure effectively without causing significant changes to heart rate. Laboratories supporting pharmaceutical development rely on accurate reference standards for Urapidil Hydrochloride to ensure stringent quality control and regulatory compliance. This category encompasses the active pharmaceutical ingredient along with a comprehensive selection of related compounds, including synthetic impurities, degradation products, and metabolites such as 1-(2-methoxyphenyl)piperazine. These compounds are essential for reliable impurity profiling, method validation, and rigorous analytical testing. Researchers also utilize stable isotope-labelled standards to serve as internal controls, facilitating precise quantification and structural characterization in complex biological and pharmaceutical matrices.